# Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli

> **NCT05287724** · EARLY_PHASE1 · COMPLETED · sponsor: **Wright State University** · enrollment: 20 (actual)

## Conditions studied

- Pruritus
- Skin Disorder

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05287724
- **Lead sponsor:** Wright State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-19
- **Primary completion:** 2024-01-04
- **Final completion:** 2024-01-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287724, "Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05287724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*